General Drug Manufacturer stocks
16 General Drug Manufacturer companies worth $1B or more: the 10 highest-scored first, then all of them by size. The median scores 64/100 as of Nov 19, 2026. Each score is 80% fundamentals, judged against Healthcare companies rather than the whole market, and 20% technicals. Another 1 smaller General Drug Manufacturer companies are scored in the app.
Highest-scored General Drug Manufacturer stocks
| Company | Industry | Market cap | Score |
|---|---|---|---|
| LLY Eli Lilly and Company | Drug Manufacturers - General | $1.20T | 73 |
| AZN AstraZeneca | Drug Manufacturers - General | $272.0B | 68 |
| AMGN Amgen | Drug Manufacturers - General | $237.4B | 67 |
| JNJ Johnson & Johnson | Drug Manufacturers - General | $643.1B | 65 |
| GILD Gilead Sciences | Drug Manufacturers - General | $206.6B | 64 |
| NVO Novo Nordisk A/S | Drug Manufacturers - General | $171.3B | 64 |
| NVS Novartis | Drug Manufacturers - General | $285.6B | 64 |
| BMY Bristol-Myers Squibb Company | Drug Manufacturers - General | $119.3B | 64 |
| ABBV AbbVie | Drug Manufacturers - General | $501.2B | 63 |
| GSK GSK | Drug Manufacturers - General | $95.9B | 63 |
All 16 General Drug Manufacturer stocks by market cap
| Company | Industry | Market cap | Score |
|---|---|---|---|
| LLY Eli Lilly and Company | Drug Manufacturers - General | $1.20T | 73 |
| JNJ Johnson & Johnson | Drug Manufacturers - General | $643.1B | 65 |
| ABBV AbbVie | Drug Manufacturers - General | $501.2B | 63 |
| MRK Merck & Co. | Drug Manufacturers - General | $327.4B | 62 |
| NVS Novartis | Drug Manufacturers - General | $285.6B | 64 |
| AZN AstraZeneca | Drug Manufacturers - General | $272.0B | 68 |
| AMGN Amgen | Drug Manufacturers - General | $237.4B | 67 |
| GILD Gilead Sciences | Drug Manufacturers - General | $206.6B | 64 |
| NVO Novo Nordisk A/S | Drug Manufacturers - General | $171.3B | 64 |
| PFE Pfizer | Drug Manufacturers - General | $157.0B | 57 |
| BMY Bristol-Myers Squibb Company | Drug Manufacturers - General | $119.3B | 64 |
| SNY Sanofi | Drug Manufacturers - General | $110.6B | 60 |
| GSK GSK | Drug Manufacturers - General | $95.9B | 63 |
| BIIB Biogen | Drug Manufacturers - General | $36.5B | 60 |
| GRFS Grifols | Drug Manufacturers - General | $5.6B | 60 |
| OGN Organon | Drug Manufacturers - General | $3.7B | 60 |